ArticleBMC cancer2022

Exploring complement-dependent cytotoxicity by rituximab isotypes in 2D and 3D-cultured B-cell lymphoma.

Sandra Lara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.